Cite
HARVARD Citation
Karajannis, M. et al. (n.d.). HGG-06. Phase 2 Study of Veliparib and Local Irradiation, Followed by Maintenance Veliparib and Temozolomide, in Patients with Newly Diagnosed High-Grade Glioma without H3 K27M or BRAF Mutations: A Report from the Children's Oncology Group ACNS1721 Study. Neuro-oncology. pp. i60-i61. [Online].